Benign skin lesions

Benign skin lesions are common and represent a frequent indication in aesthetic and dermatological practice. They include seborrhoeic keratoses, verrucae seborrhoicae, syringomas, xanthelasma, fibromas, naevi (where indicated) and other benign epidermal or superficial dermal lesions.

Successful treatment calls for careful consideration of the type of lesion, its depth, its anatomical location, the patient's skin type and the desired cosmetic outcome. The objective is removal that is as complete as possible, with minimal thermal damage to surrounding tissue and the smallest possible risk of scarring or pigment change.

Technologies for benign skin lesions

For most benign skin lesions, ablative lasers are the gold standard. Systems such as the eCO2 3D, Erbium:YAG and UltraClear make it possible to vaporise tissue layer by layer under precise control. That precision lets the practitioner match the depth of ablation closely to the lesion, sparing as much healthy surrounding skin as possible and allowing excellent cosmetic results.

The choice between a CO₂ laser, Erbium:YAG or the UltraClear depends on the indication, the degree of thermal effect wanted and the practitioner's preference. Where some lesions benefit from more coagulation, others call for maximum precision with minimal heat diffusion.

Notably, the Alexandrite laser of the Clarity II can also be a highly valuable treatment option for specific benign skin lesions. Using high fluences and a small spot size, the Alexandrite laser can be applied in a controlled way to vaporise superficial lesions precisely. The technique offers a safe and effective treatment for selected indications, making it a valuable addition within a versatile laser platform.

In practice

Treating benign skin lesions is among the most rewarding indications in laser practice. Results are often immediately visible, treatments can be carried out efficiently, and patient satisfaction is generally high.

Having several ablative technologies available, complemented by the distinctive capabilities of the Alexandrite laser, means a suitable treatment strategy can be chosen for virtually any benign skin lesion. This gives practitioners the flexibility to pursue the optimal result, both functionally and cosmetically.

Medi-Invest supports practitioners with clinical training, practice-oriented treatment protocols and technical guidance, so that every technology can be deployed safely and effectively in the treatment of benign skin lesions.